Skip to content

AMS shares surge 16% as private equity takeover talks heat up

A potential £615M bid sends AMS shares rocketing—but will TA Associates seal the deal? Investors bet big as London's M&A frenzy accelerates.

The image shows a graph depicting the increased BAA issuance across industry groups. The graph is...
The image shows a graph depicting the increased BAA issuance across industry groups. The graph is accompanied by text that provides further information about the data.

Private equity predators swoop on Advanced Medical Solutions

AMS shares surge 16% as private equity takeover talks heat up

Private equity predators have swooped on Advanced Medical Solutions (AMS), taking the number of London-listed companies involved in takeover talks so far this year to 20.

US buyout group TA Associates is in discussions with the British wound-care specialist about making an offer believed to be worth 280p a share.

That would value AMS at £615m, and its shares yesterday rose 16.2 per cent, or 37p, to 265p.

TA Associates has until May 16 to table a firm offer or walk away.

'There can be no certainty that a firm offer will be made,' an AMS spokesman said after confirming talks were under way.

The approaches to AMS and William Hill owner Evoke mean that 20 London-listed firms are involved in bid discussions already this year, according to analysis by broker AJ Bell.

The total value of the bids on the table is £29.3billion - the same as all the successful bids in 2025 and the largest sum at this stage for any year this decade.

AJ Bell investment director Russ Mould said: 'This year is off to a fast start, despite the wider geopolitical uncertainty and concerns over what the long-term implications of the wars in the Middle East and Eastern Europe could be.'

Read also:

Latest